MeMed raises $93M to accelerate commercialization of its host immune-response product portfolio
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Stay updated with breaking news from Union Tech Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
The company said it will use the funds to scale manufacturing and accelerate commercialization of its MeMed BV and MeMed COVID-19 Severity tests.
MeMed's technology rapidly distinguishes bacterial and viral infections, and can predict which Covid-19 patients need drug treatment.
Fabric claims to become a new breed of unicorn following $200 million funding led by Singapore's state investment firm Temasek.
Tactile Mobility's software uses autonomous vehicle's existing sensors to provide it with a better grasp of road conditions; company has existing agreements with Porsche, BMW